Related references
Note: Only part of the references are listed.A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients
Holly LaDuca et al.
GENETICS IN MEDICINE (2020)
A quantitative model to predict pathogenicity of missense variants in the TP53 gene
Cristina Fortuno et al.
HUMAN MUTATION (2019)
TP53 variants of uncertain significance: increasing challenges in variant interpretation and genetic counseling
Camila Matzenbacher Bittar et al.
FAMILIAL CANCER (2019)
Importance of gastric cancer for the diagnosis and surveillance of Japanese Lynch syndrome patients
Tsuneo Ikenoue et al.
JOURNAL OF HUMAN GENETICS (2019)
Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation
Fumito Yamazaki et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2018)
Mutational processes shape the landscape of TP53 mutations in human cancer
Andrew O. Giacomelli et al.
NATURE GENETICS (2018)
Sources of discordance among germ-line variant classifications in ClinVar
Shan Yang et al.
GENETICS IN MEDICINE (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel
Bradford Coffee et al.
CANCER GENETICS (2017)
Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging A Meta-analysis
Mandy L. Ballinger et al.
JAMA ONCOLOGY (2017)
Global Cancer Incidence and Mortality Rates and Trends-An Update
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
Lisa R. Susswein et al.
GENETICS IN MEDICINE (2016)
Risks of First and Subsequent Cancers Among TP53 Mutation Carriers in the National Cancer Institute Li-Fraumeni Syndrome Cohort
Phuong L. Mai et al.
CANCER (2016)
TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
Liacine Bouaoun et al.
HUMAN MUTATION (2016)
Combined steroidogenic characters of fetal adrenal and Leydig cells in childhood adrenocortical carcinoma
Yasuko Fujisawa et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study
Anita Villani et al.
LANCET ONCOLOGY (2016)
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
Gaelle Bougeard et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Frequent occurrence of gastric cancer in Asian kindreds with Li-Fraumeni syndrome
H. Ariffin et al.
CLINICAL GENETICS (2015)
Anaplastic Rhabdomyosarcoma in TP53 Germline Mutation Carriers
Simone Hettmer et al.
CANCER (2014)
Prevalence of Germline TP53 Mutations in a Prospective Series of Unselected Patients with Adrenocortical Carcinoma
Victoria M. Raymond et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
Nataliya Zhukova et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Functional Studies of a Novel Germline p53 Splicing Mutation Identified in a Patient With Li-Fraumeni-Like Syndrome
Jinhua Piao et al.
MOLECULAR CARCINOGENESIS (2013)
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Linda Holmfeldt et al.
NATURE GENETICS (2013)
A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil
Juliana Giacomazzi et al.
VIRCHOWS ARCHIV (2013)
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort
Serena Masciari et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: The Children's Hospital Los Angeles (CHLA) experience, 1991-2010
Alexa E. Gozali et al.
PEDIATRIC BLOOD & CANCER (2012)
The germline TP53 mutation c.722 C>T promotes bone and liver tumorigenesis at a young age
Tomoo Osumi et al.
PEDIATRIC BLOOD & CANCER (2012)
Association of Germline or Somatic TP53 Missense Mutation with Oncogene Amplification in Tumors Developed in Patients with Li-Fraumeni or Li-Fraumeni-like Syndrome
Waka Sugawara et al.
GENES CHROMOSOMES & CANCER (2011)
Gastric cancer in individuals with Li-Fraumeni syndrome
Serena Masciari et al.
GENETICS IN MEDICINE (2011)
Dominant-Negative Features of Mutant TP53 in Germline Carriers Have Limited Impact on Cancer Outcomes
Paola Monti et al.
MOLECULAR CANCER RESEARCH (2011)
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study
Anita Villani et al.
LANCET ONCOLOGY (2011)
Pleomorphic carcinoma of the lung arising in a patient with Li-Fraumeni syndrome: Report of a case
Tatsuya Kato et al.
SURGERY TODAY (2011)
Novel Germ Line Mutation p53-P177R in Adult Adrenocortical Carcinoma Producing Neuron-specific Enolase as a Possible Marker
Hisamitsu Ide et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes
Marielle W. G. Ruijs et al.
JOURNAL OF MEDICAL GENETICS (2010)
Acute Lymphoblastic Leukemia After Temozolomide Treatment for Anaplastic Astrocytoma in a Child With a Germ line TP53 Mutation
Hiroyuki Momota et al.
PEDIATRIC BLOOD & CANCER (2010)
Identification and characterization of a novel germline p53 mutation in a patient with glioblastoma and colon cancer
Hidetaka Yamada et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Detection of R337H a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil
Edenir Inez Palmero et al.
CANCER LETTERS (2008)
A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
Naohiro Izawa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
Molecular basis of the Li-Fraumeni syndrome:: an update from the French LFS families
G. Bougeard et al.
JOURNAL OF MEDICAL GENETICS (2008)
Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population
Hidetaka Yamada et al.
CARCINOGENESIS (2007)
Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers
Lawrence R. Dearth et al.
CARCINOGENESIS (2007)
Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome
P Wong et al.
GASTROENTEROLOGY (2006)
Molecular genetics of adrenocortical tumours, from familial to sporadic diseases
R Libé et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
A patient with TP53 germline mutation developed Bowen's disease and myelodysplastic syndrome with myelofibrosis after chemotherapy against ovarian cancer
K Kuribayashi et al.
INTERNAL MEDICINE (2005)
Multiple primary cancers in patients with osteosarcoma - Influence of anticancer drugs and genetic factors
T Yonemoto et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2004)
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis
S Kato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A novel case with germline p53 gene mutation having concurrent multiple primary colon tumours
M Miyaki et al.
GUT (2003)
Relative frequency and morphology of cancers in carriers of germline TP53 mutations
JM Birch et al.
ONCOGENE (2001)
Germline p53 mutation in a patient with multiple primary cancers
K Kimura et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2001)
Sensitivity and predictive value of criteria for p53 germline mutation screening
A Chompret et al.
JOURNAL OF MEDICAL GENETICS (2001)
Share Paper
